[Mucoepidermoidcarcinoma - Importance in molecular pathology]

Area of Science:

• Oncology
• Genetics
• Pathology

Background:

• Mucoepidermoid carcinoma is the most common salivary gland malignancy.
• Tumor grading significantly impacts prognosis, with lower grades showing higher survival rates.
• The t(11;19)(q21;p13) translocation, forming the CRTC1-MAML2 fusion, is being investigated for prognostic relevance.

Purpose of the Study:

• To investigate the prognostic significance of the CRTC1-MAML2 fusion in mucoepidermoid carcinoma.
• To determine the association between the t(11;19) translocation and clinicopathological features.
• To explore the potential therapeutic implications of the translocation's presence or absence.

Main Methods:

• Detection of the t(11;19)(q21;p13) translocation using molecular methods.
• Correlation of translocation status with tumor grade, patient age, tumor stage, and metastasis.
• Analysis of survival data based on fusion status.

Main Results:

• The CRTC1-MAML2 fusion was detected in 38-82% of mucoepidermoid carcinomas.
• Fusion-positive tumors showed a significantly better prognosis than fusion-negative tumors.
• The t(11;19) translocation was more frequent in low/intermediate grade tumors, younger patients, smaller tumors, and cases without lymph node or distant metastases.

Conclusions:

• The CRTC1-MAML2 fusion is a significant prognostic marker in mucoepidermoid carcinoma, associated with favorable outcomes.
• The absence of this translocation may guide decisions for escalating therapy in selected cases.
• Further research is needed to fully elucidate the therapeutic value of the CRTC1-MAML2 fusion.